Applied Therapeutics Ownership
| APLT Stock | USD 1.69 0.06 3.43% |
Shares in Circulation | First Issued 2018-03-31 | Previous Quarter 49.3 M | Current Value 14.4 M | Avarage Shares Outstanding 32.5 M | Quarterly Volatility 22.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Applied |
Applied Stock Ownership Analysis
About 95.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.42. Applied Therapeutics had not issued any dividends in recent years. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Applied Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. For more info on Applied Therapeutics please contact the company at 212 220 9226 or go to https://www.appliedtherapeutics.com.Besides selling stocks to institutional investors, Applied Therapeutics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Applied Therapeutics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Applied Therapeutics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Applied Therapeutics Quarterly Liabilities And Stockholders Equity |
|
About 5.0% of Applied Therapeutics are currently held by insiders. Unlike Applied Therapeutics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Applied Therapeutics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Applied Therapeutics' insider trades
Applied Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Applied Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Applied Therapeutics backward and forwards among themselves. Applied Therapeutics' institutional investor refers to the entity that pools money to purchase Applied Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Simplify Asset Management Inc. | 2024-09-30 | 2.8 M | Tang Capital Management Llc | 2024-09-30 | 2.7 M | Deutsche Bank Ag | 2024-06-30 | 2.3 M | Geode Capital Management, Llc | 2024-09-30 | 2.1 M | Rock Springs Capital Management Lp | 2024-09-30 | 1.7 M | Stempoint Capital Lp | 2024-09-30 | 1.6 M | Opaleye Management Inc | 2024-09-30 | 1.3 M | Vestal Point Capital Lp | 2024-09-30 | 1.1 M | T. Rowe Price Associates, Inc. | 2024-09-30 | 1 M | Hhg Plc | 2024-09-30 | 10.5 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 9.9 M |
Applied Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Applied Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Applied Therapeutics Outstanding Bonds
Applied Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Applied Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Applied bonds can be classified according to their maturity, which is the date when Applied Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| APPLIED MATLS INC Corp BondUS038222AG04 | View | |
| APPLIED MATERIALS INC Corp BondUS038222AN54 | View | |
| APPLIED MATERIALS INC Corp BondUS038222AP03 | View | |
| APPLIED MATLS INC Corp BondUS038222AJ43 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.